ERBB2 and breast carcinoma: Breast cancer molecular subtypes are based on the expression of hormone receptors such as estrogen and progesterone receptors; the presence of additional copies of the gene for Human Epidermal Growth Factor Receptor 2 (HER2); and Ki-67 levels, which serve as a measurement of cellular proliferation [22].